Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 28, 2016; 22(8): 2512-2523
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2512
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2512
Group | n | Fasting blood glucose (mg/dL) | IRI (ng/dL) | HOMA-IR |
MCS 4 wk | 6 | 520 ± 51 | 19.7 ± 5.4 | 26.4 ± 8.1 |
MCD + saline 4 wk | 8 | 126 ± 13a | 4.3 ± 1.4a | 1.4 ± 0.5a |
MCD + exendin-4 4 wk | 8 | 109 ± 7 | 2.4 ± 0.9b | 0.7 ± 0.3b |
MCS 8 wk | 6 | 707 ± 99 | 5.3 ± 3.6 | 9.4 ± 6.9 |
MCD + saline 8 wk | 8 | 133 ± 12c | 4.2 ± 0.5c | 1.4 ± 0.5c |
MCD + exendin-4 8 wk | 8 | 94 ± 8.7 | 1.1 ± 0.2d | 0.3 ± 0.04d |
- Citation: Yamamoto T, Nakade Y, Yamauchi T, Kobayashi Y, Ishii N, Ohashi T, Ito K, Sato K, Fukuzawa Y, Yoneda M. Glucagon-like peptide-1 analogue prevents nonalcoholic steatohepatitis in non-obese mice. World J Gastroenterol 2016; 22(8): 2512-2523
- URL: https://www.wjgnet.com/1007-9327/full/v22/i8/2512.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i8.2512